Organization Overview
Alternative names
loxapine (loxitane) (2012)
Asthma (Phase 1)
Breakthrough Pain (Phase 1)
Cardiotoxicity (Phase 1)
Disease (Phase 3)
Epilepsy (Phase 2)
Headache (Phase 2)
Lung Diseases (Phase 1)
Lung Diseases, Obstructive (Phase 1)
Migraine Disorders (Phase 2)
Panic Disorder (Phase 2)
Parkinson Disease (Phase 1)
Psychomotor Agitation (Phase 3)
Pulmonary Disease, Chronic Obstructive (Phase 1)
Schizophrenia (Phase 3)
Syndrome (Phase 2)
Vomiting (Phase 2)